Bredinin



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 36.2%
Renal Transplant 20.2%
Drug Use For Unknown Indication 7.4%
Nephrotic Syndrome 5.6%
Glomerulonephritis Membranous 3.9%
Prophylaxis 3.2%
Infection Prophylaxis 2.9%
Osteoporosis 2.4%
Antibiotic Prophylaxis 2.1%
Product Used For Unknown Indication 2.1%
Graft Versus Host Disease 1.9%
Diabetes Mellitus 1.8%
Hypertension 1.6%
Hyperlipidaemia 1.5%
Gastritis 1.4%
Abdominal Pain 1.3%
Prophylaxis Against Graft Versus Host Disease 1.3%
Stem Cell Transplant 1.3%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Osteoporosis Prophylaxis 0.9%
Urine Output Decreased 10.9%
Pulmonary Tuberculosis 9.8%
Sepsis 8.7%
White Blood Cell Count Increased 7.6%
Pneumocystis Jiroveci Pneumonia 5.4%
Toxic Epidermal Necrolysis 5.4%
Urinary Tract Infection 5.4%
Diffuse Large B-cell Lymphoma 4.3%
Lymphoproliferative Disorder 4.3%
Tonsillectomy 4.3%
Weight Increased 4.3%
Diabetes Mellitus 3.3%
Hypertriglyceridaemia 3.3%
Intervertebral Disc Protrusion 3.3%
Lymph Node Tuberculosis 3.3%
Neutropenia 3.3%
Pericarditis 3.3%
Pneumonia Bacterial 3.3%
Rash Generalised 3.3%
Rib Fracture 3.3%
Concomitant
Rheumatoid Arthritis 52.3%
Renal Transplant 12.5%
Prophylaxis 5.3%
Hypertension 4.7%
Osteoporosis 3.7%
Nephrotic Syndrome 2.4%
Product Used For Unknown Indication 2.4%
Prophylaxis Against Transplant Rejection 2.3%
Focal Segmental Glomerulosclerosis 1.9%
Systemic Lupus Erythematosus 1.8%
Hyperlipidaemia 1.3%
Interstitial Lung Disease 1.3%
Pain 1.3%
Antibiotic Prophylaxis 1.1%
Colitis Ulcerative 1.1%
Lupus Nephritis 1.1%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Gastritis 1.0%
Insomnia 0.8%
Gastritis Prophylaxis 0.7%
Pneumonia 9.2%
Respiratory Failure 7.6%
Renal Tubular Necrosis 6.9%
White Blood Cell Count Decreased 6.9%
Pancreatic Carcinoma 6.1%
Pneumocystis Jiroveci Pneumonia 6.1%
Visual Impairment 6.1%
Interstitial Lung Disease 4.6%
Loss Of Consciousness 4.6%
Pyrexia 4.6%
Vocal Cord Paralysis 4.6%
Hepatic Function Abnormal 3.8%
Melaena 3.8%
Polyarteritis Nodosa 3.8%
Progressive Multifocal Leukoencephalopathy 3.8%
Rheumatoid Arthritis 3.8%
Viral Infection 3.8%
White Blood Cell Count Increased 3.8%
Anaemia 3.1%
Humerus Fracture 3.1%